NEUROMARK Randomized Controlled Trial
Completed · Not applicable · NCT06128200
Conditions: Chronic Rhinitis
At a glance
- Research payments reported, 2025
- $321,249
- U.S. investigators named
- 0
- Sites paid
- 0
- Planned or actual enrollment
- 132
About the trial
- Sponsor
- Neurent Medical
- Tested
- NEUROMARK System (device), Sham NEUROMARK System (device)
- Dates
- Started 2023-10-10; completion 2025-11-26
- Results posted
- Not yet
The NEUROMARK RCT Study is a prospective, multicenter, randomized, sham-controlled, single-blinded, superiority trial.
From ClinicalTrials.gov, last updated 2026-03-19. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Neurent Medical Limited reported $321,249 in research payments for this study in 2025 (34 payments).
Products named: Neuromark System, Neuromark Radiofrequency Console
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
Sites paid to run it
- $321,249
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.